These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4671781)

  • 1. [Importance of the plasma growth hormone level (HGH) on the development of diabetic retinopathy].
    Sévin R
    Bull Mem Soc Fr Ophtalmol; 1972; 85(0):213-20. PubMed ID: 4671781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone in developmental diabetic retinopathy].
    Grange JD; Borson-Chazot F; Adad B; Cohen R; Sassolas G; Berthezene F
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):699-700, 703-4. PubMed ID: 2590989
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the pathogenesis of diabetic retinopathy--observation on serum growth hormone].
    Zhu ZR
    Zhonghua Yan Ke Za Zhi; 1984 Mar; 20(2):71-3. PubMed ID: 6435967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy].
    Parlapiano C; Paoletti V; Campana E; Rota C; Donnarumma L; Musca A; Andreani D
    Minerva Med; 1995 Mar; 86(3):105-20. PubMed ID: 7603606
    [No Abstract]   [Full Text] [Related]  

  • 10. The correlation between human growth hormone (HGH) concentration in blood plasma and the evolution of diabetic retinopathy.
    Sévin R
    Ophthalmologica; 1972; 165(1):71-7. PubMed ID: 5069892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Somatotropic hormone in the serum of diabetics].
    Dobrev D; Manolov D; Vakov L
    Vutr Boles; 1981; 20(2):49-53. PubMed ID: 7257332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids and lipoproteins in retinopathy of type I (insulin-dependent) diabetic patients.
    Sinav S; Onelge MA; Onelge S; Sinav B
    Ann Ophthalmol; 1993 Feb; 25(2):64-6. PubMed ID: 8447652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus. Lectures held in Cairo and Alexandria, January 1966.
    Poulsen JE
    Acta Endocrinol (Copenh); 1967; ():Suppl 118:5-95. PubMed ID: 5340062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth hormone level in the blood serum after fasting in diabetes mellitus in relation to the degree of compensation, the presence of obesity and retinopathy].
    Avenirova ZA; Alekeseeva GG; Stepanova NA
    Probl Endokrinol (Mosk); 1973; 19(3):3-8. PubMed ID: 4724060
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basal blood level of thyrotropic hormone in diabetes mellitus patients].
    Vakov L; Milanov S
    Vutr Boles; 1984; 23(2):92-7. PubMed ID: 6741116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prekallikrein as a risk factor for diabetic retinopathy.
    Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
    Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen level in patients with type I diabetes with and without retinopathy].
    Sobol A
    Acta Haematol Pol; 1995; 26(1):57-62. PubMed ID: 7747564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma prostacyclin-stimulating activity in diabetes mellitus.
    Wiles PG; Johnson M
    Horm Metab Res; 1985 Nov; 17(11):610-1. PubMed ID: 3908270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.